(ANIX) Anixa Biosciences - Performance 38.3% in 12m
ANIX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-13.66%
#38 in Peer-Group
Rel. Strength
80.94%
#1468 in Stock-Universe
Total Return 12m
38.33%
#29 in Peer-Group
Total Return 5y
-4.85%
#35 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.97 USD |
| 52 Week Low | 2.13 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 52.31 |
| Buy/Sell Signal +-5 | -1.59 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ANIX (38.3%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ANIX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ANIX
| Total Return (including Dividends) | ANIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -7.65% | 0.53% | 3.75% |
| 3 Months | 31.93% | 21.37% | 25.32% |
| 12 Months | 38.33% | -9.11% | 13.11% |
| 5 Years | -4.85% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | ANIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -57.3% | -5.7% | 80.3% |
| 3 Months | 62.4% | 79.4% | 97.2% |
| 12 Months | -26.8% | -86.9% | 45.4% |
| 5 Years | -20.4% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th34.50 | -8.13% | -10.99% |
| 3 Month | %th58.50 | 8.70% | 5.28% |
| 12 Month | %th86.00 | 52.19% | 22.29% |
| 5 Years | %th84.00 | 28.57% | -54.64% |
FAQs
Does Anixa Biosciences (ANIX) outperform the market?
Yes,
over the last 12 months ANIX made 38.33%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months ANIX made 31.93%, while XBI made 21.37%.
Performance Comparison ANIX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ANIX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.2% | -11.4% | 33.7% | 25% |
| US NASDAQ 100 | QQQ | -3.8% | -11.8% | 32.1% | 27% |
| German DAX 40 | DAX | -5.1% | -7.9% | 20.9% | 8% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.3% | -11.4% | 30% | 17% |
| Hongkong Hang Seng | HSI | -2.8% | -10.7% | 13.2% | -1% |
| India NIFTY 50 | INDA | -2.5% | -8.5% | 33.1% | 39% |
| Brasil Bovespa | EWZ | -2.5% | -13.5% | 11.7% | 31% |
ANIX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.9% | -11.2% | 29.2% | 14% |
| Consumer Discretionary | XLY | -2.5% | -9.6% | 41.5% | 22% |
| Consumer Staples | XLP | -2% | -8.1% | 33.2% | 30% |
| Energy | XLE | -6.4% | -14.4% | 37.4% | 36% |
| Financial | XLF | -1.9% | -10.4% | 31.1% | 10% |
| Health Care | XLV | -1.5% | -8.7% | 42.6% | 43% |
| Industrial | XLI | -3.4% | -10.8% | 26.8% | 14% |
| Materials | XLB | -4.1% | -11.4% | 30.1% | 33% |
| Real Estate | XLRE | -2.1% | -7.5% | 34.8% | 27% |
| Technology | XLK | -4.9% | -14.8% | 29.6% | 28% |
| Utilities | XLU | -1.8% | -8.9% | 31.3% | 17% |
| Aerospace & Defense | XAR | -3.9% | -11.4% | 15.5% | -10% |
| Biotech | XBI | -4.8% | -8.2% | 47.8% | 47% |
| Homebuilder | XHB | -2% | -13.7% | 41.6% | 35% |
| Retail | XRT | -3.3% | -9.2% | 38.4% | 29% |
ANIX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -6.9% | -14.5% | 40.0% | 43% |
| Natural Gas | UNG | -0.9% | 2.8% | 52.9% | 45% |
| Gold | GLD | -1.7% | -6.9% | 15.9% | -1% |
| Silver | SLV | -4.5% | -7.4% | 18.1% | 20% |
| Copper | CPER | -9.8% | -17.7% | 13.3% | 20% |
ANIX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.4% | -8.7% | 37.4% | 42% |
| iShares High Yield Corp. Bond | HYG | -2.6% | -9% | 35.3% | 29% |